Reckitt Benckiser Group plc (LON:RKT – Get Rating) has been given a consensus recommendation of “Buy” by the nine ratings firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 7,332.50 ($93.46).
Several research analysts recently weighed in on RKT shares. JPMorgan Chase & Co. restated an “overweight” rating on shares of Reckitt Benckiser Group in a research note on Monday, April 4th. Berenberg Bank dropped their target price on Reckitt Benckiser Group from GBX 7,480 ($95.34) to GBX 7,460 ($95.08) and set a “buy” rating on the stock in a research note on Wednesday, March 23rd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 7,200 ($91.77) target price on shares of Reckitt Benckiser Group in a research note on Tuesday, April 5th. Royal Bank of Canada restated a “sector perform” rating and set a GBX 5,500 ($70.10) target price on shares of Reckitt Benckiser Group in a research note on Friday, April 1st. Finally, Barclays boosted their target price on Reckitt Benckiser Group from GBX 8,800 ($112.16) to GBX 9,100 ($115.98) and gave the stock an “overweight” rating in a research note on Friday, April 1st.
Shares of LON:RKT opened at GBX 6,240 ($79.53) on Friday. Reckitt Benckiser Group has a 12-month low of GBX 4,905.16 ($62.52) and a 12-month high of GBX 6,709 ($85.51). The business’s fifty day simple moving average is GBX 5,948.36 and its 200-day simple moving average is GBX 6,040.41. The company has a market capitalization of £44.61 billion and a PE ratio of -1,386.67. The company has a current ratio of 0.62, a quick ratio of 0.40 and a debt-to-equity ratio of 129.26.
About Reckitt Benckiser Group (Get Rating)
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.